drugset
drugset / Trial / NCT00975039

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

NCT00975039 ↗

Phase 2 Terminated 8 enrolled Steba Biotech S.A.
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the safety of Vascular Targeted Photodynamic therapy with WST11 in patients with non-resectable or inoperable biliary carcinoma.

Timeline

Start
2009-09
Primary completion
2011-06
Completion
2012-09

Outcome

Outcome not reported

Stopped: “Early end of enrolment with regards to difficulty met to enrol patients .”

Drugs

EvaluationDrugModalityDoseRoute
Subject Padeliporfin Other / unclassified 2.5 mg/kg Intravenous
Subject Padeliporfin Other / unclassified 5 mg/kg Intravenous

Indications

cholangiocarcinoma